Warning! GuruFocus detected
3 Severe warning signs
with ENZ.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Enzo Biochem Inc
NAICS : 621511
SIC : 8071
ISIN : US2941001024
Description
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 14.61 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | -0.51 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -4.35 | |||||
| Beneish M-Score | -2.88 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -36.4 | |||||
| 3-Year FCF Growth Rate | -84.4 | |||||
| 3-Year Book Growth Rate | -8.8 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.12 | |||||
| 9-Day RSI | 35.88 | |||||
| 14-Day RSI | 33.97 | |||||
| 3-1 Month Momentum % | -50 | |||||
| 6-1 Month Momentum % | -54.05 | |||||
| 12-1 Month Momentum % | -58.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.55 | |||||
| Quick Ratio | 2.28 | |||||
| Cash Ratio | 2.04 | |||||
| Days Inventory | 155.65 | |||||
| Days Sales Outstanding | 50.72 | |||||
| Days Payable | 32.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 20.11 | |||||
| Forward Dividend Yield % | 80.41 | |||||
| 5-Year Yield-on-Cost % | 20.11 | |||||
| 3-Year Average Share Buyback Ratio | -2.5 | |||||
| Shareholder Yield % | 56.28 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.39 | |||||
| Operating Margin % | -34.69 | |||||
| Net Margin % | -75.34 | |||||
| FCF Margin % | -74.6 | |||||
| ROE % | -35.93 | |||||
| ROA % | -24.83 | |||||
| ROIC % | -31.68 | |||||
| 3-Year ROIIC % | 68.81 | |||||
| ROC (Joel Greenblatt) % | -48.65 | |||||
| ROCE % | -11.56 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.85 | |||||
| PB Ratio | 0.55 | |||||
| Price-to-Tangible-Book | 0.55 | |||||
| EV-to-EBIT | 2.62 | |||||
| EV-to-EBITDA | 3.16 | |||||
| EV-to-Revenue | -0.67 | |||||
| EV-to-FCF | 0.9 | |||||
| Price-to-GF-Value | 0.5 | |||||
| Price-to-Net-Current-Asset-Value | 0.82 | |||||
| Price-to-Net-Cash | 1.31 | |||||
| Earnings Yield (Greenblatt) % | 38.17 | |||||
| FCF Yield % | -87.01 | |||||
| Forward Rate of Return (Yacktman) % | 54.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ENZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzo Biochem Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 30.314 | ||
| EPS (TTM) ($) | -0.45 | ||
| Beta | 1.25 | ||
| 3-Year Sharpe Ratio | -0.56 | ||
| 3-Year Sortino Ratio | -1.06 | ||
| Volatility % | 46.22 | ||
| 14-Day RSI | 33.97 | ||
| 14-Day ATR ($) | 0.043597 | ||
| 20-Day SMA ($) | 0.48877 | ||
| 12-1 Month Momentum % | -58.54 | ||
| 52-Week Range ($) | 0.4122 - 1.32 | ||
| Shares Outstanding (Mil) | 52.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzo Biochem Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzo Biochem Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzo Biochem Inc Frequently Asked Questions
What is Enzo Biochem Inc(ENZ)'s stock price today?
The current price of ENZ is $0.50. The 52 week high of ENZ is $1.32 and 52 week low is $0.41.
When is next earnings date of Enzo Biochem Inc(ENZ)?
The next earnings date of Enzo Biochem Inc(ENZ) is 2025-06-13 Est..
Does Enzo Biochem Inc(ENZ) pay dividends? If so, how much?
The Dividend Yield %  of Enzo Biochem Inc(ENZ) is 20.11% (As of Today), Highest Dividend Payout Ratio of Enzo Biochem Inc(ENZ) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Enzo Biochem Inc(ENZ) is 80.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers